| 000 | 01584nam a22004095a 4500 | ||
|---|---|---|---|
| 005 | 20250930125126.0 | ||
| 006 | m d | ||
| 007 | cr nn 008maaau | ||
| 008 | 100623s2008 nyu j eng d | ||
| 020 | _a9780387758411 (electronic bk.) | ||
| 020 | _a9780387758404 (paper) | ||
| 035 | _a(Springer)978-0-387-75840-4 | ||
| 039 | 9 |
_a201006230933 _bmuhaimin _y02-04-2009 _zmuhaimin |
|
| 082 |
_a616.079 _222 |
||
| 090 | _aebook | ||
| 245 | 0 | 0 |
_aImmunogenicity of Biopharmaceuticals _h[electronic resource] / _cedited by Marco van de Weert, Eva Horn Moller. |
| 260 |
_aNew York, NY : _bAmerican Association of Pharmaceutical Scientists, _c2008. |
||
| 300 |
_axi, 263 p., [2] p. of plates : _bill. (some col.), digital ; _c27 cm. |
||
| 440 | 0 |
_aBiotechnology: Pharmaceutical Aspects ; _vVIII |
|
| 650 | 0 |
_aBiopharmaceutics _xImmunology. |
|
| 650 | 0 |
_aPharmaceutical biotechnology. _960734 |
|
| 650 | 1 | 4 | _aBiomedicine. |
| 650 | 2 | 4 | _aImmunology. |
| 650 | 2 | 4 | _aPharmacology/Toxicology. |
| 700 | 1 | _aWeert, Marco van de. | |
| 700 | 1 | _aMoller, Eva Horn. | |
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 856 | 4 | 0 | _uhttps://link.springer.com/book/10.1007/978-0-387-75841-1 |
| 856 | 4 | 0 | _uhttps://link.springer.com.eresourcesptsl.ukm.remotexs.co/book/10.1007/978-0-387-75841-1 |
| 907 |
_a.b14384346 _b2024-01-11 _c2019-11-12 |
||
| 942 |
_n0 _kebook |
||
| 914 | _avtls003397359 | ||
| 998 |
_ah _b2009-04-02 _cm _dz _feng _gnyu _y0 _z.b14384346 |
||
| 999 |
_c433182 _d433182 |
||